Atkinson Edward Morrow III sold VRTX
February 20, 2024 · Form 4 insider transaction
Atkinson Edward Morrow III sold 801 shares of Vertex Pharmaceuticals Incorporated at $420.79 per share, a transaction worth $337.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
801
Price
$420.79
Total value
$337.1K
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 20, 2024
Filing dateFebruary 21, 2024
Shares owned after19,710
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 8/22/2023.